In vitro activity of newer β-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens
References (22)
- et al.
Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital
Lancet
(1976) - et al.
Antibiotic susceptibility testing by a standardized single disk method
Am J Pathol
(1966) - et al.
Antibiotic sensitivity testing: Report of an international collaborative study
Acta Pathol Microbiol Scand Sect B
(1971) Comparative in vitro activities of β -lactam-tobramycin combinations against Pseudomonas aeruginosa and multidrug-resistant gram-negative enteric bacilli
Antimicrob Agents Chemother
(1982)- et al.
In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic
Antimicrob Agents Chemother
(1976) - et al.
Effect of the concentrations of magnesium and calcium on the in vitro susceptibility of Pseudomonas aeruginosa to gentamicin
J Infect Dis
(1971) - et al.
In vitro evaluation of cefoperazone
Antimicrob Agents Chemother
(1980) - et al.
Moxalactam (LY127935), a new semisynthetic l-oxa-β-lactam antibiotic with remarkable antimicrobial activity: In vitro comparison with cefamandole and tobramycin
Antimicrob Agents Chemother
(1980) - et al.
Antimicrobial activity of amikacin combinations against Entero-bacteriaceae moderately susceptible to third-generation cephalosporins
Antimicrob Agents Chemother
(1982) - et al.
Ceftizoxime (FK 749), a new parenteral cephalosporin: In vitro and in vivo antibacterial activities
Antimicrob Agents Chemother
(1979)
Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens
Antimicrob Agents Chemother
(1981)
Cited by (0)
Copyright © 1983 Published by Elsevier Inc.